Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Professor David Nutt presents his insights into psychedelic medicine - Neural Therapeutics

Neural Therapeutics Inc.

Neural Therapeutics Scientific Advisory Board Member Professor David Nutt presents fascinating insights into psychedelic medicine and its potential uses. His pioneering research, influencing Australia's adoption of psychedelic medicines, underscores a pivotal moment in mental health care. Nutt highlighted the historical journey of psychedelics, from widespread research in the 1950s and 60s to their banning due to misperceptions about safety and efficacy. This ban, tied to political motives, stifled research for decades. Recent studies, however, have rekindled interest, demonstrating the low harm and high efficacy of psychedelics compared to other substances, particularly in clinical settings. Professor Nutt's work reveals significant breakthroughs in treating conditions like treatment-resistant depression, addiction, and alcoholism using psychedelics like psilocybin and mescaline. His team's studies show unprecedented success rates, often with just a single dose, offering hope for those with chronic mental health issues. These findings are supported by neuroimaging studies that illustrate how psychedelics promote neuroplasticity, enabling the brain to forge new, healthier thought patterns. This revival of psychedelic research marks a revolution in mental health treatment, offering new pathways for those who have not benefited from traditional therapies. The Australian regulatory body's recent approval of psilocybin for treatment-resistant depression exemplifies this shift. Nutt's presentation, a blend of historical context, scientific evidence, and a call for compassionate use, heralds a new era in mental health care, emphasizing the potential of psychedelics to transform lives. For further reading, Nutt recommends his co-edited book on psychedelics in psychiatry and a forthcoming book for the general public. The presentation is introduced by Neural Therapeutics CEO and Director Ian Campbell. Neural Therapeutics is a drug-discovery company focusing on plant-based active substances with the goal of delivering beneficial, over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments where no significant treatment is available today. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

December 12, 2023 10:22 AM Eastern Standard Time

Video

New Report Highlights Weight Stigma in Media and Calls for Change

Media Empathy Foundation

A new national survey conducted for the Media Empathy Foundation sheds light on pervasive weight stigma in media, revealing that individuals with higher body weight perceive negative stereotypes, body shaming, weight blaming and exclusion from leading roles in TV and other forms of media. The report, titled “Weight Stigma and Media: Assessing the Impact”, draws attention to harmful impact and emphasizes the need for more inclusive and respectful representations across all channels. The study surveyed more than 1,200 U.S. adults with a Body Mass Index (BMI) of 30 or higher, a demographic that accounts for 42% of American adults within the range of obesity according to the U.S. Centers for Disease Control and Prevention. The findings reveal a concerning pattern of problematic media portrayals with potentially detrimental consequences and underscores the need for consistent, compassionate, and accurate representation of individuals with higher body weight in media. The findings were discussed by a panel of leaders in media (Deborah Roberts, Al Roker and David Sloan) and academia (Rebecca Puhl, PhD and Holly Lofton, MD) at the Edge in NYC. “Weight stigma in the media exists in both blatant and subtle ways, reinforcing harmful attitudes and societal weight bias of people with higher body weight. There is a clear need for more respectful and compassionate media portrayals of people of diverse body sizes,” said Rebecca Puhl, PhD, Deputy Director for the Rudd Center for Food Policy & Health and Professor in the Department of Human Development and Family Sciences at the University of Connecticut. Key findings from the report include: High Prevalence: Most respondents assert that social media (73%), TV shows and movies (65%) and TV news (55%) often or sometimes perpetuate negative stereotypes about individuals with higher body weight. Only a small minority (5% or less) feel that this never happens. Health News Stereotyping: Respondents say that health news reports tend to blame people for their weight (70%) and suggest that all people with higher body weight are unhealthy (79%). Terminology Matters: A notable 88% of those surveyed find the term “fat” to be offensive or inappropriate, more so than “morbidly obese”, while “plus-size” and “overweight” are seen as appropriate by more than half. Negative Personal Impact: One in three respondents report that media portrayals have made them feel disrespected, with about as many reporting negative effects on their body image and self-esteem. One in four report negative effects on their mental health. Desired Change: Respondents are calling on creators to focus on character attributes beyond body type and to eliminate weight-based stereotypes, humor, or derogatory portrayals, advocating for more inclusive roles and realistic character development, as well as emphasizing health and wellness without resorting to shaming. Holly Lofton, MD, Clinical Associate Professor of Medicine and Surgery and Director of the Medical Weight Management Program at NYU Langone Health added, “It’s important that health news media more consistently report on the complex causes of obesity rather than assuming it’s the result of poor willpower or self-discipline.” “The media industry shapes the way we think and has the power to create a more aware and supportive culture for people with higher body weight,” said Helene Ellison, Founder and President of the Media Empathy Foundation. “That’s our hope in bringing weight stigma to the forefront.” The report was produced for the Media Empathy Foundation by Langer Research Associates and was made possible thanks to the support of Novo Nordisk Inc. For more information on the Media Empathy Foundation and to access the full survey findings, please visit: https://www.mediaempathy.org/. For more information on obesity, visit the Obesity Action Coalition at: https://www.obesityaction.org/. For PR Inquiries and more information on the upcoming panel discussion, contact: Kristen Long Communications, Kristen@kristenlongcommunications.com About the Media Empathy Foundation: The Media Empathy Foundation is a 501(c)(3) nonprofit organization that was founded with the mission to reduce health stigma by promoting empathy, compassion, and inclusivity in all forms of media. Contact Details Media Empathy Foundation Helene Ellison info@mediaempathy.org Company Website https://www.mediaempathy.org/

December 12, 2023 09:04 AM Eastern Standard Time

Investing in the U.S. Health Care Sector with the Health Care Select Sector SPDR Fund (XLV)

Select Sector SPDR

The health care industry is an ever-present sector in the investment landscape, offering steady growth and resilience even during challenging times, thanks to factors like aging demographics, which drive the performance of companies in this sector. For investors looking to gain exposure to this robust market, the Health Care Select Sector SPDR Fund ( XLV ) presents a cost-effective and efficient option. XLV provides broad exposure to core companies within the U.S. health care industry by tracking health care stocks from the S&P 500 Index, weighted by market cap. Top holdings* include UnitedHealth Group (10.54%), Lilly (9.70%), Johnson & Johnson (7.66%), Merck (5.35%), AbbVie (5.17%), and Thermo Fisher (3.94%), representing more than 40% of the fund. About the Health Care Select Sector SPDR Fund (XLV) Launched in 1998, XLV is the oldest health care ETF in the market. With over $37 billion in assets under management and a low total expense ratio of 0.10%**, this fund offers easy access to major players in the pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries. The health care industry is one of the largest in the U.S. economy, with demand remaining consistent due to the essential nature of its services. This ETF capitalizes on that demand, providing focused exposure to leading health care names. XLV has proven to be a useful tool for investors seeking strategic or tactical positions in the health care sector. Moreover, the transparency of XLV is one of its main advantages. Investors can follow daily portfolio holdings and weightings at sectorspdrs.com, ensuring they are always informed about their investments. As consumer spending on health care continues to rise year over year, XLV represents a valuable opportunity to capture this steady growth. The Health Care Select Sector SPDR Fund ( XLV ) allows easy access to the largest companies in the health care industry. As an investment vehicle, it offers a diversified methodology that can fit portfolios and investment strategies in a broad market manner, making it a practical tool for investors of all sizes. DISCLAIMER: This is a work of research and should not be taken as investment or financial advice. Therefore, Select Sector SPDRs or the publisher is not liable for any decision made based on the publication. About the Company: Select Sector SPDR ETFs offer flexibility and customization opportunities. Many investors have similar outlooks, but no two are exactly alike. Select Sector SPDR ETFs let investors select the sectors that best meet their investment goals. *Holdings, Weightings & Assets as of 11/30/23 subject to change **Ordinary brokerage fees apply DISCLOSURES The S&P 500 Index is an unmanaged index of 500 common stocks that is generally considered representative of the U.S. stock market. The index is heavily weighted toward stocks with large market capitalizations and represents approximately two-thirds of the total market value of all domestic common stocks. The S&P 500 Index figures do not reflect any fees, expenses or taxes. An investor should consider investment objectives, risks, fees and expenses before investing. One may not invest directly in an index. Transparent ETFs provide daily disclosure of portfolio holdings and weightings All ETFs are subject to risk, including loss of principal. Sector ETF products are also subject to sector risk and nondiversification risk, which generally will result in greater price fluctuations than the overall market. Diversification does not eliminate risk. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information, call 1-866-SECTOR-ETF (732-8673) or visit www.sectorspdrs.com. Read the prospectus carefully before investing. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is distributor for the Select Sector SPDR Trust. Media Contact: Company: Select Sector SPDRs Contact: Dan Dolan* Address: 1290 Broadway, Suite 1000, Denver, CO 80203 Country: United States Email: dan.dolan@sectorspdrs.com Website: https://www.sectorspdrs.com/ *Dan Dolan is a Registered Representative of ALPS Portfolio Solutions Distributor, Inc. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is the distributor for the Select Sector SPDR Trust. SEL007096 EXP 1/31/24 Contact Details Dan Dolan +1 203-935-8103 dan.dolan@sectorspdrs.com Company Website https://www.sectorspdrs.com/

December 12, 2023 07:00 AM Eastern Standard Time

Contract Management Institute Announces New Governance Board

National Contract Management Association

National Contract Management Association’s (NCMA) Contract Management Institute (CMI), an institution dedicated to advancing the profession of contract management is thrilled to introduce its newly appointed Governance Board for the 2023-2024 term. These accomplished professionals will play a pivotal role in guiding the strategic direction of CMI and ensuring the organization's success. "Having had the privilege of working alongside these distinguished professionals throughout my career, I am absolutely thrilled and deeply proud to welcome them to the newly revitalized CMI," stated CMI's Executive Director and former Department of Homeland Security Chief Procurement Officer, Soraya Correa. "Their exceptional expertise and dedication will undoubtedly contribute to our shared vision, and I look forward to the extraordinary journey ahead." NCMA Chief Executive Officer, Kraig Conrad will become the Board Chair for CMI. He expressed his excitement, saying, "I am delighted and honored to serve as Chair for the Institute. CMI is poised to become an important extension of NCMA, providing valuable resources to elevate our profession. I look forward to our journey together and the positive impact we will make." Denyce Carter, the current Board Chair of NCMA, will be joining Kraig Conrad as a distinguished addition and Vice Chair to the CMI board. She said, "I look forward to being part of an initiative that identifies and creates ways to enhance contract management practices, ultimately improving the profession for the workforce and the broader acquisition community." Along with Mr. Conrad and Ms. Carter, the Governance Board includes several accomplished professionals – including three NCMA past Presidents – that bring a wealth of knowledge and experience to the CMI board, representing a diverse range of organizations from government agencies and industry leaders to top consulting firms. The full list includes: Amanda Christian, Senior Vice President of Subcontracts and Procurement at CACI International Inc. She is responsible for setting direction, policy, and procedures based upon corporate-level strategy, and ensuring that procurement and subcontracts personnel provide value and contribute to the overall success of the company. Amanda is a Past-President of NCMA and served on its Board of Directors for seven years. She is a Fellow and currently serves on the Board of Advisors. Alan Chvotkin, Partner at Centre Law Group where he specializes in federal government contracts law and its policies and practices, including counseling companies on a wide range of matters from contract formation and performance through disputes and claims. Mr. Chvotkin is a Fellow of NCMA and currently serves on its Board of Advisors. Kim Denver, Senior Vice President and Chief Contracts Executive at Leidos, leads a team of over 250 contracts professionals, overseeing a diverse portfolio of thousands of active contracts, and previously held a key role as Deputy Assistant Secretary of the Army for Procurement. Mr. Denver currently serves on NCMA’s Board of Advisors. Wendy Masiello is currently an independent consultant, having retired from the U.S. Air Force as a three-star general in July 2017. During her 36-year career with the Air Force, she served as director of the Defense Contract Management Agency; deputy assistant secretary (contracting), Office of the Assistant Secretary of the Air Force for Acquisition; and program executive officer for the Air Force’s $30 billion service acquisition portfolio. She is an NCMA Past-President, and currently a member of the Board of Directors for KBR Inc. and Board of Advisors for NCMA and the Public Spend Forum Debra Scheider is Vice President, Corporate Contracts for Lockheed Martin Corporation. She is responsible for leading the Corporations Contracting, Industrial Development, and Estimating work encompassing policies, strategies, training, and procedures across the Corporation. Ms. Scheider is Past-President of NCMA and served on its Board of Directors for nine years. She is a Fellow of NCMA and currently serves on the Board of Advisors. She is a Director for the Procurement Round Table. Karla Smith Jackson, currently serving as the Senior Procurement Executive, Deputy Chief Acquisition Officer, and Assistant Administrator for Procurement at NASA, is a seasoned professional with extensive expertise with more than three decades of federal contracting experience. Her noteworthy background is in program management, acquisition, and contract planning. She is currently a member of the NCMA Board of Directors. Charlie Williams, President, CWilliams, LLC., held a number of pivotal roles that significantly contributed to the field of contract management., Notably, he served as the Deputy Assistant Secretary, Contracting for the United States Air Force, Director of the Defense Contract Management Agency (DCMA), Commissioner on the Section 809 Panel, President of the NCMA Board of Directors, Chair of the NCMA Standards Consensus Body, a valued member of the NCMA Board of Advisors, and a distinguished Member of the NASA Advisory Council. CMI is dedicated to fostering excellence in contract management by conducting research, studies, and analyses that promote engagement, standards, professional development, and enhanced business practices. The new Governance Board will play a pivotal role in guiding the organization's strategic direction and ensuring the continued growth and success of CMI. For more information about the Institute and its Governance Board, please visit ncmahq.org/cmi. The National Contract Management Association (NCMA) – www.ncmahq.org – stands as the premier contract management organization whose mission is to collaborate towards a globally recognized contract management profession that strengthens its nexus with related acquisition communities. Serving approximately 20,000 members in both the public and private sectors, NCMA propels the growth, advancement, and impact of practitioners through a steadfast commitment to serve through the open exchange of ideas in neutral forums. Contact Details National Contract Management Association Holly DeHesa +1 281-865-3296 holly.dehesa@ncmahq.org Company Website https://www.ncmahq.org

December 12, 2023 05:00 AM Eastern Standard Time

Image

USA Benefits Group Partners with AmeriLife to Expand Agent Opportunities & Serve More Clients

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions, announced today that it has partnered with USA Benefits Group, a fast-growing, national health brokerage dedicated to delivering the highest quality products, service, and support to independent agencies, agents, and their clients. Per the agreement, terms of the deal were not disclosed. “We see this partnership as a power play to further USA Benefits Group's explosive growth,” said Rick Banville, CEO of USA Benefits Group. “AmeriLife is a rapidly expanding giant in the industry who takes the pressure off of agencies like ours through resources like HR, payroll, compliance, legal, marketing, recruiting, and technology so we can do what we do best: recruit and train agents and agencies to be successful. We are very excited about our bright future together.” “We are so grateful and honored to become partners with AmeriLife,” added Jessica Banville, president of USA Benefits Group. “We are thrilled that our agents and clients will benefit from an even larger portfolio of products and support. This partnership will give us even greater opportunity in making the industry better as we continue to develop training systems that bring success to all. We are stronger together!” For more than three decades, USA Benefits Group has been at the forefront of helping agents and their clients navigate the complexities of health and ancillary insurance (including ACA and ACA alternatives) for the under-65 market. Over the years, the company has expanded its portfolio to include Medicare Advantage and Medicare Supplement insurance, life insurance, and health insurance benefits for small businesses, as well as developed proprietary tools and training for its insurance professionals to succeed and thrive. Headquartered in nearby Spring Hill, Fla., USA Benefits Group boasts nearly 2,000 independent contracted agents nationwide. Now, with access to AmeriLife’s best-in-class resources, deep product portfolio, and industry expertise and leadership, USA Benefits Group is primed to supercharge its growth and deliver even more value to beneficiaries across the United States. “I’m excited to welcome Rick, Jessica and the USA Benefits Group family to ours,” said Scotty Elliott, Chief Distribution Officer for AmeriLife Health. “Our shared values and commitment to excellence in service makes this a winning partnership right out of the gate, and I can’t wait to see what we can accomplish together.” ### About USA Benefits Group USA Benefits Group is a nationwide insurance agency dedicated to the principles of service, integrity, professionalism and diversity. The company provides an extensive range of insurance products and pledges to honor its commitment to its producers, clients and carriers by holding itself to the highest ethical standards. Everything that USA Benefits Group does is designed to ensure that its customers are presented quality products with a “Servant’s Heart” and a goal of exceeding expectations. For more information, visit USABG.com. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as a leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

December 11, 2023 10:10 AM Eastern Standard Time

Faron Pharmaceuticals presents "very positive" Phase 1 data at ASH Conference

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief executive Dr Markku Jalkanen speaks to Thomas Warner from Proactive London after the clinical stage biopharmaceutical company announced "very positive" Phase 1 data from the ongoing BEXMAB study in myeloid malignancies. The data is being presented at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition taking place until tomorrow, December 12, 2023, in San Diego, California, and virtually. Jalkanen says the data reveals a promising response in patients, especially in inducing myeloid differentiation in Myelodysplastic Syndrome (MDS), a condition with limited treatment options Typically, patients with this type of cancer have a life expectancy of around 24 months, making these results particularly significant. Investors and shareholders have responded positively to this latest news, as the trial shows a response rate potentially 5 to 10 times higher than the current standard of care. Faron Pharmaceuticals is now preparing to advance to the next trial phases and is exploring potential partnerships. Regarding the company's overall performance in 2023, Dr. Jalkanen expresses satisfaction with Faron's ability to maintain and even increase its pace, with promising data accumulating from ongoing trials and the initiation of new ones. The company is targeting a marketing approval application by 2025, staying on track with its previously set goals. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 11, 2023 10:09 AM Eastern Standard Time

Video

PathPresenter Selected by Cincinnati Children’s to Provide Comprehensive Digital Pathology Workflow Solution

PathPresenter

PathPresenter, the global image sharing platform for pathology, was recently selected by Cincinnati Children’s to provide an integrated digital pathology workflow solution to meet the health system’s requirements across clinical care, remote consultations, education, and research. Cincinnati Children’s, which ranks No. 1 in the nation in U.S. News & World Report’s listing of Best Children’s Hospitals for 2023-24, recently completed an extensive selective process to procure a comprehensive digital pathology workflow solution. Cincinnati Children’s, utilizing PathPresenter’s platform, seeks to improve workflow efficiencies (enabled by tight integration with its laboratory information system); expand its digital consultation network; provide new educational capabilities to advance clinical competency testing; and enable enhanced research capabilities with the ability to connect any type of AI algorithm – from 3 rd party vendors or developed in-house. PathPresenter is a secure and scalable multi-tenant enterprise workflow platform that has been developed by pathologists with deep domain knowledge and experience. Trusted by 45+ tier-one institutions, PathPresenter is the most comprehensive suite available for clinical care, remote consultations, education, and research. With expert guidance in storage optimization, tight integration with LIS systems through a proprietary HL7 engine, and robust incorporation of 3 rd party and in-house-built AI algorithms, PathPresenter ensures genuine value to institutions – without the marketing noise. While Cincinnati Children’s doesn’t endorse or sponsor any commercial products, services, or companies, Dr. Jennifer Picarsic, MD, director of Digital Pathology and AP Informatics at Cincinnati Children’s, noted that a successful digital pathology program relies not just on scanning and viewing digital slides, but rather a re-imagined vision for how pathology will be practiced in the future. “As pathology leaders, we seek to build a new digitally integrated workflow that will enhance clinical, education and research opportunities to facilitate new innovations and wider access to our expert pathologists from anywhere in the world,” Picarsic said. Dr. Rajendra Singh, founder of PathPresenter, added “We are honored to work with the excellent clinical and technical teams at Cincinnati Children’s, given their thorough understanding and deep knowledge of what they need from a workflow provider with a complete focus on improving efficiencies ensuring better care of their precious patients. PathPresenter was created to fill in the gaps in use of digital pathology, and this further fulfills our mission.” About PathPresenter PathPresenter is the global image sharing platform for pathology. We are on a mission to help democratize access to the world’s pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, PathPresenter has been adopted by 45+ tier one medical institutions for clinical care, remote consultations, education, and research, and has built a thriving community of 50,000+ users in 172 countries to easily view and share digital pathology images and knowledge. For more information visit www.pathpresenter.com. Contact Details Cory Batenchuk +1 873-355-9913 cory@pathpresenter.com Company Website https://pathpresenter.com

December 11, 2023 09:00 AM Eastern Standard Time

Research Shows New Single-Use Protein A Capture Technology Offers 10X Productivity Over Standard Resin Columns for Antibody Purification

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new research paper from its global research and development Center (R&D Center) titled, Building a Fully Single-Use Process: High Productivity Protein A Membrane Devices that Complement Disposable Upstream Technology. In the research, the CDMO’s scientists feature exclusive data on the promise of new single-use devices that alleviate common monoclonal antibody (mAb) purification problems that can occur when using standard Protein A resin columns. The new research is available immediately and offers biopharma developers a glimpse into the promise of single-use technology for the Protein A membrane capture chromatography step, using the GORE® Protein Capture Devices with Protein A as a technology use case. The paper also features conclusions on the benefits of this innovative technology, such as reduced manufacturing footprint, reduction in lead-time and consumable costs, and more. There are several important topics covered in the study, including: Overview of protein A capture technology: A recap of the promise offered by single-use membrane chromatography technologies; including their ability to operate with a high flow rate and achieve high productivity and disposable process; featured performance data on manufacturing scales of Protein A membrane devices, including small scale and manufacturing scale comparisons. Benefits single-use devices offer to the manufacturing process: When paired with single-use bioreactor upstream strategies, the research found contamination risk, operation time relating to preparation and cleaning, and operator error were all reduced. The technology also offers cost savings, reduced risk, lower bioburden, greater speed to market, and other benefits. Purification productivity data: single-use devices vs. standard resin: Protein A membrane devices showed 10 times higher productivity than the Protein A resin column on the purification of mAb cultures. Other data includes productivity details, including removal of host cell proteins (HCP) and host cell DNA, when compared with resin columns, reduction in bioburden, time savings, and more. R&D review: implementing protein A membrane device into traditional manufacturing flows: A review of the implementation process for these devices and how they can be implemented for all vessels and into existing flow-paths, the ion exchange membrane device, and single-use TFF membrane capsules, while improving efficiencies to purify mAb in a short process time. The AGC Biologics R&D Center focuses on modernizing and advancing processes and technologies used for biopharmaceutical development and manufacturing capabilities. The scientists within the team are responsible for developing and implementing new procedures and evaluating innovations that help developers of protein biologics and advanced therapies improve titers/yields, cell line development, downstream purification analytical analysis, and more. To learn more about AGC Biologics visit https://www.agcbio.com/. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 2,500 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice. To learn more, visit www.agcbio.com. Contact Details AGC Biologics Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

December 11, 2023 06:03 AM Eastern Standard Time

Epicenter of Healthcare Transformation: The Intelligent Health Association's 2023 International Summit starts tomorrow, Monday, December 11

1BusinessWorld

In an era where technological evolution is pivotal to healthcare advancements, the Intelligent Health Association (IHA) proudly announces the launch of its 2023 International Summit. This year's summit, occurring from December 11 to December 15, 2023, represents a paradigm shift in healthcare conferences. Embracing a fully virtual format, the summit ensures accessibility for all, enabling professionals globally to engage with leading healthcare insights without the constraints of physical attendance. https://1businessworld.com/2023-intelligent-health-summit/ Reimagining Healthcare Through Digital Transformation The Intelligent Health Association is at the forefront of orchestrating an event that mirrors the current landscape of healthcare - a blend of technological innovation and practical applications. This summit is not just an event; it's an intellectual symposium, bringing together the brightest minds to discuss, debate, and shape the future of healthcare. Key Topics and Educational Excellence Over the course of five days, the summit will delve into critical areas such as AI's impact on healthcare, cybersecurity in patient data management, advancements in telehealth, the imperatives of health equity, and the integration of innovative technologies in healthcare settings. Each day is meticulously crafted to offer a comprehensive understanding of these key areas: - Exploring the role of AI in enhancing healthcare delivery. - Navigating the complexities of data and cybersecurity in healthcare. - Evaluating the evolution of telehealth in a post-pandemic era. - Championing the cause of global health equity. - Understanding the necessity of change management in adopting new technologies. A Commitment to Continuing Medical Education In an effort to empower healthcare professionals worldwide, the IHA, in collaboration with the Weitzman Institute, is offering Continuing Medical Education (CME) credits for this summit. This initiative underscores our commitment to ongoing professional development in the healthcare sector. Leadership Insights and Global Collaboration Harry P. Pappas, Founder and CEO of the Intelligent Health Association, emphasizes the summit's role in shaping healthcare's future. "This summit represents a confluence of thought leadership and innovative practices that are essential for the evolution of healthcare. We are creating a forum where ideas meet implementation," remarks Pappas. Echoing this sentiment, Sherri Douville, CEO at Medigram and Co-Chair of the Intelligent Health Summit, highlights the summit's multidisciplinary approach. "Our objective is to forge a nexus of technology, policy, and healthcare. This summit is a testament to our dedication to driving healthcare forward through leadership and transformation," states Douville. Invitation to Join a Transformative Journey The Intelligent Health Association extends an invitation to healthcare professionals, industry experts, policymakers, and academicians to join this groundbreaking event. The fully virtual format of this summit opens doors for a global audience, making it an inclusive and easily accessible platform for sharing and learning. Together, we can chart a new course for healthcare that is more adaptive, equitable, and innovative. https://1businessworld.com/2023-intelligent-health-summit/ All news and content distribution in partnership with News Direct. About the Intelligent Health Association: The Intelligent Health Association (IHA) is a global consortium of healthcare and technology leaders committed to advancing digital healthcare. Our goal is to disseminate unbiased information on innovative technologies that enhance patient care and improve clinical and business processes. The IHA champions the transformation of healthcare through high-quality educational programs and networking events, facilitating the adoption and implementation of new technologies in health and wellness ecosystems. We are dedicated to reshaping healthcare through innovation and leadership, ensuring a future where technology seamlessly integrates with patient care. Intelligent Health Association About 1BusinessWorld: 1BusinessWorld is a global business ecosystem, network and marketplace that provides entrepreneurs, business owners and professionals with the information, tools, resources and connectivity needed to succeed throughout their company’s growth journey, toward a better business world. Our vision is based on the reality that we live, work and do business in one global interconnected business environment, and hence our motto: “One World, One Business World”. Our mission is to encourage and support global communication and collaboration among entrepreneurs, professionals, and businesses. 1BusinessWorld Contact Details Media Enquiries +1 212-220-6677 info@1businessworld.com Company Website https://1businessworld.com

December 10, 2023 02:04 PM Eastern Standard Time

Image

1 ... 68 69 70 71 72 ... 304